Fluorometholone Acetate

CAS No. 3801-06-7

Fluorometholone Acetate ( AI3-52814, Flarex, Fluorometholone acetate; U 17,323 )

Catalog No. M17725 CAS No. 3801-06-7

Fluorometholone Acetate is a synthetic corticosteroid, used in the treatment of steroid responsive inflammatory conditions of the eye.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 50 In Stock
100MG 72 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fluorometholone Acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    Fluorometholone Acetate is a synthetic corticosteroid, used in the treatment of steroid responsive inflammatory conditions of the eye.
  • Description
    Fluorometholone acetate is an anti-inflammatory that may be useful in the reduction of ocular inflammation.
  • Synonyms
    AI3-52814, Flarex, Fluorometholone acetate; U 17,323
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    Glucocorticoid Receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    3801-06-7
  • Formula Weight
    418.5
  • Molecular Formula
    C24H31FO5
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    [H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)C[C@]([H])(O)[C@@]1(F)[C@@]2([H])C[C@]([H])(C)C2=CC(=O)C=C[C@]12C
  • Chemical Name
    9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 17-acetate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kupferman A, et al. Arch Ophthalmol, 1982, 100(4), 640-641.
molnova catalog
related products
  • GDC-0927 R-form

    GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD).

  • 4-hydroxyestrone-4-m...

    4-hydroxyestrone-4-methyl ether is the methylation of 4-OHE1, which is catalyzed by COMT.

  • GDC-0810

    GDC-0810 (ARN-810, Brilanestrant) is a non-steroidal, orally bioavailable selective estrogen receptor degrader (SERD) with IC50 of 0.7 nM (ER-α degradation).